In October 2024, a team of Chinese researchers at Peking University reported that a 25-year-old woman who had lived with Type 1 diabetes since childhood stopped needing insulin injections within 75 days of receiving an experimental stem cell transplant ge

In October 2024 a team at Peking University reported that a 25‑year‑old woman with lifelong Type 1 diabetes stopped needing insulin injections within 75 days after receiving an experimental stem‑cell transplant. Coverage highlights the case as a sign of potential progress.

Rockdale Citizen and KGUN 9 note that a clinical trial is expanding, while Diabetes In Control discusses whether stem‑cell therapy could change care for the disease. The Spokesman‑Review features reader responses, and Space Daily repeats the original October 2024 report.

Future reporting will focus on whether additional participants achieve similar outcomes, how regulators respond, and what next‑phase trial data emerge, according to the outlets tracking the story.